Source: Clinical nuclear medicine. Unidade: FM
Subjects: NEOPLASIAS MAMÁRIAS, NEOPLASIAS PROSTÁTICAS, METÁSTASE NEOPLÁSICA
ABNT
ROCHA, Nelisa Helena et al. Comparison of oral and IV 18F-NaF PET/CT administration in the assessment of bone metastases in patients with breast or prostate cancers. Clinical nuclear medicine, v. 48, n. 9, p. E413-E419, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56049. Acesso em: 10 nov. 2024.APA
Rocha, N. H., Zacchi, S. R., Sado, H. N., Buchpiguel, C. A., Duarte, P. S., & Sapienza, M. T. (2023). Comparison of oral and IV 18F-NaF PET/CT administration in the assessment of bone metastases in patients with breast or prostate cancers. Clinical nuclear medicine, 48( 9), E413-E419. doi:10.1097/RLU.0000000000004745NLM
Rocha NH, Zacchi SR, Sado HN, Buchpiguel CA, Duarte PS, Sapienza MT. Comparison of oral and IV 18F-NaF PET/CT administration in the assessment of bone metastases in patients with breast or prostate cancers [Internet]. Clinical nuclear medicine. 2023 ; 48( 9): E413-E419.[citado 2024 nov. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56049Vancouver
Rocha NH, Zacchi SR, Sado HN, Buchpiguel CA, Duarte PS, Sapienza MT. Comparison of oral and IV 18F-NaF PET/CT administration in the assessment of bone metastases in patients with breast or prostate cancers [Internet]. Clinical nuclear medicine. 2023 ; 48( 9): E413-E419.[citado 2024 nov. 10 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56049